 MONMOUTH JUNCTION, N.J., May 25, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care leader commercializing its CytoSorb blood purification technology to treat deadly conditions in the intensive care unit ICU and cardiac surgery, announces that the Singapore Health Sciences Authority HSA has now approved registration of CytoSorb for all equivalent European Union E.U. 